SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-089382
Filing Date
2022-08-11
Accepted
2022-08-11 16:30:58
Documents
47
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K evax-20220630x6k.htm   iXBRL 6-K 79969
2 EXHIBIT 99.1 evax-20220630xex99d1.htm   iXBRL EX-99.1 660711
3 EXHIBIT 99.2 evax-20220630xex99d2.htm EX-99.2 166604
  Complete submission text file 0001104659-22-089382.txt   3724845

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA evax-20220630.xsd EX-101.SCH 51177
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evax-20220630_cal.xml EX-101.CAL 36826
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evax-20220630_def.xml EX-101.DEF 178018
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE evax-20220630_lab.xml EX-101.LAB 406457
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evax-20220630_pre.xml EX-101.PRE 293306
41 EXTRACTED XBRL INSTANCE DOCUMENT evax-20220630x6k_htm.xml XML 398901
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 221156360
SIC: 2836 Biological Products, (No Diagnostic Substances)